The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion

NCT01951729 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Pre-diabetes

Interventions

DRUG: Control
DRUG: Xenin-25 without atropine
DRUG: GIP without atropine
DRUG: Placebo with atropine
DRUG: Xenin-25 with atropine
DRUG: GIP with atropine
DRUG: GIP plus Xenin-25 without atropine
DRUG: GIP plus Xenin-25 with atropine

Sponsor

Washington University School of Medicine

Collaborators

[object Object]